ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2019
vol. 28
 
Share:
Share:
more
 
 
abstract:
Review paper

The role of resistance to acetylsalicylic acid in patients with ischemic stroke

Adam Wiśniewski
1
,
Karolina Filipska
2

1.
Department of Neurology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
2.
Department of Neurological and Neurosurgical Nursing, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
Adv Psychiatry Neurol 2019; 28 (4): 257-266
Online publish date: 2019/12/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
The aim of the study was to review the current data from the literature on resistance to acetylsalicylic acid in patients with ischemic stroke, in particular its incidence, etiological mechanisms, diagnostic tests, its impact on the prognosis for patients who have suffered the stroke and the use of alternative antiplatelet therapies.

Views
Acetylsalicylic acid is the most commonly used antiplatelet drug in the treatment and prophylaxis of patients with a diagnosis of ischemic stroke. It inhibits the activation and aggregation of platelets, playing an important role in the etiopathogenesis of ischemic stroke. In many patients, the reduced sensitivity of platelets to acetylsalicylic acid contributes to the ineffectiveness of the treatment. Platelet reactivity tests allow for the estimation of the laboratory resistance to aspirin and determine its impact on the prognosis of patients with ischemic stroke.

Conclusions
The incidence of resistance to acetylsalicylic acid is common (5-65%) and has a complex, multifactorial aetiology, which significantly inhibits its therapeutic effect. Aspirin resistance worsens the ischemic stroke patients’ prognosis, both early and long-term, as has a negative impact on their clinical and functional status, mortality, size of ischemic focus and also for the tendency towards the recurrence of cerebrovascular incidents. Alternative therapies are recommended for patients with resistance to acetylsalicylic acid. Further research is required so as to enable aspirin-resistant patients to take advantage of optimized antiplatelet treatment, the effectiveness of which is a priority among this group of patients.

keywords:

stroke, aspirin resistance, platelet reactivity

Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe